Amyloid beta modulation of neuronal network activity in vitro

[1]  T. Pozzan,et al.  Aβ42 oligomers selectively disrupt neuronal calcium release , 2015, Neurobiology of Aging.

[2]  Jian Wu,et al.  The role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease , 2014, Neurobiology of Aging.

[3]  Stephen E. Saddow,et al.  Use of cortical neuronal networks for in vitro material biocompatibility testing. , 2014, Biosensors & bioelectronics.

[4]  Zhen Yan,et al.  β-Amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3 , 2014, Neurobiology of Aging.

[5]  E. Koo,et al.  Emerging therapeutics for Alzheimer's disease. , 2014, Annual review of pharmacology and toxicology.

[6]  Nathalia Peixoto,et al.  Real-time tracking of neuronal network structure using data assimilation. , 2013, Physical review. E, Statistical, nonlinear, and soft matter physics.

[7]  Hamid Charkhkar,et al.  Differential responses to ω-agatoxin IVA in murine frontal cortex and spinal cord derived neuronal networks. , 2013, Neurotoxicology.

[8]  J. Boehm,et al.  NMDA-Receptor Activation but Not Ion Flux Is Required for Amyloid-Beta Induced Synaptic Depression , 2013, PloS one.

[9]  F. Polleux,et al.  The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Aβ Oligomers through Tau Phosphorylation , 2013, Neuron.

[10]  E. Matveeva,et al.  Structure-selective anisotropy assay for amyloid Beta oligomers. , 2012, ACS chemical neuroscience.

[11]  C. Masters,et al.  Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegansfor drug screening for Alzheimer’s disease , 2012, Molecular Neurodegeneration.

[12]  Timothy Q. Duong,et al.  Methylene Blue as a Cerebral Metabolic and Hemodynamic Enhancer , 2012, PloS one.

[13]  C. Parsons,et al.  Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine – searching for the connections , 2012, British journal of pharmacology.

[14]  C. Lippa,et al.  Disease Modifying Drugs Targeting β-Amyloid , 2012, American journal of Alzheimer's disease and other dementias.

[15]  L. Mucke,et al.  Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. , 2012, Cold Spring Harbor perspectives in medicine.

[16]  L. Chew,et al.  The Toxicity of Amyloid β Oligomers , 2012, International journal of molecular sciences.

[17]  Reham M. Abdel-Kader,et al.  Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease , 2012, Molecular Neurobiology.

[18]  Hans-Ulrich Demuth,et al.  Prion-Like Behavior and Tau-dependent Cytotoxicity of Pyroglutamylated β-Amyloid , 2012, Nature.

[19]  F. Cecconi,et al.  Aβ Toxicity in Alzheimer's Disease , 2012, Molecular Neurobiology.

[20]  P. Dolan,et al.  Truncated tau and Aβ cooperatively impair mitochondria in primary neurons , 2012, Neurobiology of Aging.

[21]  B. Strooper,et al.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.

[22]  Y. Auberson,et al.  Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. , 2012, Cell Calcium.

[23]  R. Schirmer,et al.  “Lest we forget you — methylene blue …” , 2011, Neurobiology of Aging.

[24]  L. Gravitz.  Drugs: A tangled web of targets , 2011, Nature.

[25]  M. Matamales,et al.  Cellular and Molecular Life Sciences REVIEW Modes of Ab toxicity in Alzheimer’s disease , 2022 .

[26]  M. Martín-Satué,et al.  Amyloid β peptide oligomers directly activate NMDA receptors. , 2011, Cell calcium.

[27]  M. Chiappalone,et al.  Development of Micro-Electrode Array Based Tests for Neurotoxicity: Assessment of Interlaboratory Reproducibility with Neuroactive Chemicals , 2011, Front. Neuroeng..

[28]  Takahiko Shimizu,et al.  Formation of the 42-mer Amyloid β Radical and the Therapeutic Role of Superoxide Dismutase in Alzheimer's Disease , 2011, Journal of amino acids.

[29]  H. Hioki,et al.  Anti-A b Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer ’ s Disease , 2011 .

[30]  D. Selkoe,et al.  Amyloid beta dimers/trimers potently induce cofilin-actin rods that are inhibited by maintaining cofilin-phosphorylation , 2011, Molecular Neurodegeneration.

[31]  Inna Kuperstein,et al.  Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio , 2010, The EMBO journal.

[32]  Andrew F M Johnstone,et al.  Microelectrode arrays: a physiologically based neurotoxicity testing platform for the 21st century. , 2010, Neurotoxicology.

[33]  D. Wilcock.  The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease. , 2010, CNS & neurological disorders drug targets.

[34]  M. Citron,et al.  Alzheimer's disease: strategies for disease modification , 2010, Nature Reviews Drug Discovery.

[35]  T. Zako,et al.  Amyloid oligomers: formation and toxicity of Aβ oligomers , 2010, The FEBS journal.

[36]  Hyoung-Gon Lee,et al.  Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease , 2010, Neurobiology of Disease.

[37]  James J. Hickman,et al.  A New Target for Amyloid Beta Toxicity Validated by Standard and High-Throughput Electrophysiology , 2010, PloS one.

[38]  D. Teplow,et al.  Structure-neurotoxicity relationships of amyloid β-protein oligomers , 2009, Neuroscience Research.

[39]  S. Gandy,et al.  Amyloid-beta oligomers: possible roles as key neurotoxins in Alzheimer's Disease. , 2010, The Mount Sinai journal of medicine, New York.

[40]  M. Sano,et al.  An update on treatment and prevention strategies for Alzheimer’s disease , 2009, Current neurology and neuroscience reports.

[41]  Ghiam Yamin.  NMDA receptor–dependent signaling pathways that underlie amyloid β‐protein disruption of LTP in the hippocampus , 2009, Journal of neuroscience research.

[42]  Christian Lange-Asschenfeldt,et al.  Transient reduction of spontaneous neuronal network activity by sublethal amyloid β (1–42) peptide concentrations , 2009, Journal of Neural Transmission.

[43]  D. Teplow,et al.  Title Amyloid β-protein assembly and Alzheimer disease Permalink , 2009 .

[44]  S. Kar,et al.  Memantine protects rat cortical cultured neurons against β‐amyloid‐induced toxicity by attenuating tau phosphorylation , 2008, The European journal of neuroscience.

[45]  T. Gura.  Hope in Alzheimer's fight emerges from unexpected places , 2008, Nature Network Boston.

[46]  M. Fändrich,et al.  Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic mice , 2008, Journal of Molecular Medicine.

[47]  Steve M. Potter,et al.  Long-Term Activity-Dependent Plasticity of Action Potential Propagation Delay and Amplitude in Cortical Networks , 2008, PloS one.

[48]  G. Gross,et al.  Complete inhibition of spontaneous activity in neuronal networks in vitro by deltamethrin and permethrin. , 2008, Neurotoxicology.

[49]  Kathleen A. Boyle,et al.  Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  Murali Gopalakrishnan,et al.  High content screen microscopy analysis of Aβ1–42-induced neurite outgrowth reduction in rat primary cortical neurons: Neuroprotective effects of α7 neuronal nicotinic acetylcholine receptor ligands , 2007, Brain Research.

[51]  B. Bahr,et al.  Amyloid β‐peptide Aβ1–42 but not Aβ1–40 attenuates synaptic AMPA receptor function , 2007 .

[52]  Xindong Song,et al.  Microelectrode array-based system for neuropharmacological applications with cortical neurons cultured in vitro. , 2007, Biosensors & bioelectronics.

[53]  B. Bahr,et al.  Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function. , 2007, Synapse.

[54]  Alessandro Vato,et al.  Dissociated cortical networks show spontaneously correlated activity patterns during in vitro development , 2006, Brain Research.

[55]  S. Lipton.  Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond , 2006, Nature Reviews Drug Discovery.

[56]  E. Rojas,et al.  Ion channel formation by Alzheimer's disease amyloid β-peptide (Aβ40) in unilamellar liposomes is determined by anionic phospholipids , 2006, Peptides.

[57]  P. Keller,et al.  Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease , 2005 .

[58]  Steve M. Potter,et al.  Controlling Bursting in Cortical Cultures with Closed-Loop Multi-Electrode Stimulation , 2005, The Journal of Neuroscience.

[59]  F. Sherriff,et al.  Memantine for dementia. , 2005, The Cochrane database of systematic reviews.

[60]  P. Keller,et al.  Globular amyloid b-peptide 1 ) 42 oligomer ) a homogenous and stable neuropathological protein in Alzheimer ’ s disease , 2005 .

[61]  Roger Anwyl,et al.  Synaptic plasticity in animal models of early Alzheimer's disease. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[62]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[63]  M. Kirkitadze,et al.  Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies , 2002, Journal of neuroscience research.

[64]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[65]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[66]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[67]  G. Gross,et al.  Characterization of acute neurotoxic effects of trimethylolpropane phosphate via neuronal network biosensors. , 2001, Biosensors & bioelectronics.

[68]  S. Younkin,et al.  High throughput screens for the identification of compounds that alter the accumulation of the Alzheimer's amyloid β peptide (Aβ) , 2001, Journal of Neuroscience Methods.

[69]  S. Younkin,et al.  High throughput screens for the identification of compounds that alter the accumulation of the Alzheimer's amyloid beta peptide (Abeta). , 2001, Journal of neuroscience methods.

[70]  G. Gross,et al.  Drug evaluations using neuronal networks cultured on microelectrode arrays. , 2000, Biosensors & bioelectronics.

[71]  H. Tilson,et al.  In vitro techniques for the assessment of neurotoxicity. , 1998, Environmental health perspectives.

[72]  H. Bigalke,et al.  Memantine reduces repetitive action potential firing in spinal cord nerve cell cultures. , 1990, European journal of pharmacology.

[73]  G. Gross,et al.  Transparent indium-tin oxide electrode patterns for extracellular, multisite recording in neuronal cultures , 1985, Journal of Neuroscience Methods.